Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms.

Nutr Neurosci 2004 Aug;7(4):247-9

Rotherham Mental Health Services, Swallownest Court, Sheffield, S26 4TH, UK.

A previous epidemiological study found an association between high sugar consumption and two year outcome of schizophrenia. The primary aim of the present pilot study was to assess the possible relationship between dietary sugar intake and the severity of schizophrenic symptoms in a group of 20 patients. A significant negative correlation (r = -0.54, p = 0.02) between dietary sugar and severity of schizophrenic symptoms, appears to be confounded by the effect of medication. Patients taking the antipsychotic drug clozapine consumed almost twice as much sugar as those taking other antipsychotic agents, (235.4+/-92.6 g/day versus 143+/-59, p = 0.02) and had less severe symptoms. Consumption of other nutrients showed no association with clozapine treatment. In a secondary analysis, severity of schizophrenic symptoms correlated with dietary intake of polyunsaturated fatty acids (r = -0.54, p = 0.02) and this was independent of the effect of medication. This finding is consistent with earlier studies.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10284150400010012DOI Listing
August 2004

Publication Analysis

Top Keywords

schizophrenic symptoms
12
dietary sugar
12
severity schizophrenic
12
-054 002
8
polyunsaturated fatty
8
symptoms
5
severe symptoms
4
patients negative
4
symptoms group
4
group patients
4
002 severe
4
143+/-59 002
4
intake severity
4
nutrients association
4
study assess
4
association clozapine
4
assess relationship
4
relationship dietary
4
versus 143+/-59
4
sugar intake
4

Similar Publications